Sabatini et al. [47] found that the Bdkrb2 was abnormally expressed in bronchial fibroblasts from asthmatics, indicating that bradykinins were actively involved in the proliferation and differentiation of bronchial fibroblasts, as well as airway remodeling in asthma through MAPK pathway and EGF receptor transactivation. Here, BDKRB2 is linked to asthma.